Empire State Development announces completion of Niagara University Biomedical Research Institute Laboratory

Hope Knight CEO and Commissioner at New York State Economic Development
Hope Knight CEO and Commissioner at New York State Economic Development
0Comments

Empire State Development announced on Apr. 15 the completion of the Niagara University Biomedical Research Institute Laboratory, located on the Buffalo Niagara Medical Campus at 73 High Street. The new laboratory provides students with facilities to conduct research and experimentation in precision medicine and applied synthetic biology.

The opening of this laboratory is seen as a step forward for student research, STEM workforce development, and collaboration among regional institutions. Empire State Development President, CEO & Commissioner Hope Knight said, “This new laboratory is a powerful example of how strategic investment can accelerate innovation and create opportunity in Western New York. With the support of Governor Hochul, Niagara University is giving students a front-row seat to the future of medicine. I am proud to see this facility open its doors, as it will undoubtedly serve as a catalyst for life-saving research and strengthen our position as a premier hub for the health sciences.”

A $78,750 grant from Empire State Development’s Regional Council Capital Fund Program supported the project by funding advanced equipment and building out offices and lab spaces. The completed facility includes areas for analytical instrumentation, cell culture work, chemistry with chemical fume hoods, and multiple lab benches.

Rev. James J. Maher, C.M., President of Niagara University said, “This new laboratory is a direct extension of Niagara University’s mission to drive clinical research that improves human health and wellness… This investment from Empire State Development ensures our research into groundbreaking therapeutics like the Cholestosome will continue to flourish right here in Western New York.” The institute was established in 2023 with a focus on developing an innovative drug delivery system called Cholestosome aimed at advancing anti-viral therapeutics.

Dr. Mary McCourt manages the lab at Niagara University; her work centers on Cholestosome technology—holding 14 patents—and biomarker analysis related to breast cancer and Alzheimer’s disease diagnostics.

Local officials highlighted both educational opportunities for students and potential impacts on public health innovation in their statements about the project’s completion.



Leave a Reply

Your email address will not be published. Required fields are marked *

Related

Randy Wolken President & CEO at Manufacturers Association Of Central New York

Randy Wolken discusses leadership challenges in advanced manufacturing

Randy Wolken from the Manufacturers Association of Central New York says future success in advanced manufacturing depends on wise use of technology and strong human-centered leadership. He highlights the need for leaders who can balance innovation with ethics and community impact.

Hope Knight CEO and Commissioner at New York State Economic Development

Empire State Development announces grand opening of Marcus Park transformation in Olean

Empire State Development announced major renovations at Marcus Park in Olean on May 15. The upgraded site now features Cattaraugus County’s first all-inclusive playground alongside other improvements aimed at increasing accessibility.

Melinda Person President at NYSUT Media Relations Department

Federal voucher program prompts concerns for New York public schools

A new federal law will expand private school vouchers through tax credits starting in 2027. Critics say this could reduce funding for New York’s public schools while benefiting wealthier families.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from LI Business Daily.